Dabigatran Etexilate - A Novel, Reversible, Oral Direct Thrombin Inhibitor: Interpretation of Coagulation Assays and Reversal of Anticoagulant Activity
Thromb Hemost 103:1116-1127, van Ryn,J.,et al, 2010
Association Between Familial Atrial Fibrillation and Risk of New-Onset Atrial Fibrillation
JAMA 304:2263-2269, Lubitz,S.A.,et al, 2010
Personalized Approaches to Clopidogrel Therapy: Are We There Yet?
Stroke 41:2997-3002, Anderson,C.D.,et al, 2010
Hepatitis C Virus Infection and Increased Risk of Cerebrovascular Disease
Stroke 41:2894-2900, Lee,M.-H.,et al, 2010
Predictors of Subarachnoid Hemorrhage in Acute Ischemic Stroke With Endovascular Therapy
Stroke 41:2775-2781, Shi,Z.-S.,et al, 2010
Brainstem Lesion in Clinically Isolated Syndromes
Neurol 75:1933-1938, Tintore,M.,et al, 2010
Vitamin B12-Responsive Severe Leukoencephalopathy and Autonomic Dysfunction in a Patient With "Normal" Serum B12 Levels
JNNP 81:1369-1371, Graber,J.J.,et al, 2010
Successful Management of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy and Immune Reconstitution Syndrome in a Patient With Multiple Sclerosis
Arch Neurol 67:1391-1394, Schr�der,A.,et al, 2010
Recurrent Ischemic Events in Young Adults After First-Ever Ischemic Stroke
Ann Neurol 68:661-671, Putaala,J.,et al, 2010
Coffee and Acute Ischemic Stroke Onset: The Stroke Onset Study
Neurol 75:1583-1588, Mostofsky,E.,et al, 2010
AIDS-Related Lymphomas: Epidemiology, Risk Factors, and Pathobiology
UpToDate, Sept, Kaplan, L.D.,et al, 2010
Central Nervous System Involvement in Sjogrens Syndrome: Unusual, but not Unremarkable - Clinical, Serological Characteristics and Outcomes in a Large Cohort of Italian Patients
Rheumatology 49:1540-1549, Massara,A.,et al, 2010
Paraneoplastic Extra Limbic Encephalitis Associated with Thymoma
ICVTS 9:755-756, Rizzardi,G.,et al, 2009
Bilateral Thalamic Lesions
AJR 192:W53-W62, Smith,A.B.,et al, 2009
Safety of Biologic Agents After Rituximab Therapy in Patients With Rheumatoid Arthritis
Rheum Int: December 2009, Mishra, R.,et al, 2009
Best Practice Recommendations for the Selection and Management of Patients with Multiple Sclerosis Receiving Natalizumab Therapy
Mutliple Sclerosis 15:S26-S36, Coyle,P.K.,et al, 2009
Posterior Cerebral Artery Infarction: Diffusion-Weighted MRI Analysis of 205 Patients
Cerebrovasc Dis 28:298-305, Lee,E.,et al, 2009
Association of Parental Dementia With Cognitive and Brain MRI Measures in Middle-Aged Adults
Neurol 73:2071-2078, 2054, Debette,S.,et al, 2009
Intracranial Atherosclerotic Disease: An Update
Ann Neurol 66:730-738, Qureshi,A.,et al, 2009
Akinetopsia in the Posterior Cortical Variant of Alzheimer Disease
Neurol 73:731-732, Tsai,P. &Mendez,M.F., 2009
Atraumatic Lumbar Puncture Needles
The Neurologist 15:17-19, Arendt,K.,et al, 2009
Association Between Recent Sports Activity, Sports Activity in Young Adulthood, and Stroke
Stroke 40:425-431, Grau,A.J.,et al, 2009
Intracranial Aneurysm Enlargement on Serial Magnetic Resonance Angiography: Frequency and Risk Factors
Stroke 40:406-411, Burns,J.D.,et al, 2009
Isolated Lateral Sinus Thrombosis: A Series of 62 Patients
Stroke 40:476-481, Damak,M.,et al, 2009
Treatment of CNS Sarcoidosis with Infliximab and Mycophenolate Mofetil
Neurol 72:337-340, Morovan,M. &Segal,B.M., 2009
Immunologic, Clinical, and Radiologic Status 14 Months After Cessation of Natalizumab Therapy
Neurol 72:396-401,392, Stuve,O.,et al, 2009
Conventional MRI and NOTCH3 Gene Screening in Sporadic CADASIL
Neurol 72:469-471, Liguori,M.,et al, 2009
Assessment of Potential Drug Interactions in Patients with Epilepsy: Impact of Age and Sex
Neurol 72:419-425, Gidal,B.E.,et al, 2009
Early MRI in Optic Neuritis: The Risk for Disability
Neurol 72:542-550, Swanton,.K.,et al, 2009
Causes and Severity of Ischemic Stroke in Patients with Symptomatic Intracranial Arterial Stenosis
Stroke 40:1999-2003, Famain,B.M.,et al, 2009
Superficial Siderosis in the General Population
Neurol 73:202-205, Vernooij,M.W.,et al, 2009
CSF Biomarkers and Incipient Alzheimer Disease in Patients with Mild Cognitive Impairment
JAMA 302:385-393,436,452, Mattsson,N.,et al, 2009
Hearing Improvement After Bevacizumab in Patients with Neurofibromatosis Type 2
NEJM 361:358-367, Plotkin,S.R.,et al, 2009
Association Between Mid-Life Martial Status and Cognitive Function in Later Life: Population Based Cohort Study
BMJ 339:99,57, H�kansson,K.,et al, 2009
Effect of Chorioamnionitis on Brain Development and Injury in Premature Newborns
Ann Neurol 66:155-164, 127, Chau,V.,et al, 2009
Dabigatran Versus Warfarin in Patients with Atrial Fibrillation
NEJM 361:1139-1151, 1200, Connolly,S.,et al, 2009
Sarcoidosis
BMJ 339:620-625, Dempsey,O.,et al, 2009
Practice Parameter: Evaluation of the Child with Microcephaly (An Evidence-Based Review): Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society
Neurol 73:887-897, Ashwal,S.,et al, 2009
Progressive Multifocal Leukoencephalopathy After Natalizumab Monotherapy
NEJM 361:1081-1087, Linda,H.,et al, 2009
Treatment of Progressive Multifocal Leukoencephalopathy Associated with Natalizumab
NEJM 361:1075-1080, Wenning,W.,et al, 2009
Patent Foramen Ovale in Cryptogenic Stroke: Incidental or Pathogenic?
Stroke 40:2349-2355, Alsheikh-Ali,A.A.,et al, 2009
Frequency, Characteristics, and Risk Factors for Amiodarone Neurotoxicity
Arch Neurol 66:865-869, Orr,C.F. &Ahlskog,E., 2009
Brain Lesions Are Most Often Reversible in Acute Thrombotic Thrombocytopenic Purpura
Neurol 73:66-70, Burrus,T.M.,et al, 2009
Number Needed to Treat to Benefit and to Harm for Intravenous Tissue Plasminogen Activator Therapy in the 3- to 4.5-Hour Window: Joint Outcome Table Analysis of the ECASS 3 Trial
Stroke 40:2433-2437,2295, Saver,J.L.,et al, 2009
Migraine Headache in Middle Age and Late-Life Brain Infarcts
JAMA 301:2563-2570,2594, Scher,A.I.,et al, 2009
Parkinsons Disease
Lancet 373:2055-2066, Lees,A.J.,et al, 2009
The Severity of Dependence Scale Detects People with Medication Overuse: The Akershus Study of Chronic Headache
JNNP 80:784-789,704, Grande,R.B.,et al, 2009
Positron Emission Tomography in Diagnosis of Visual Variant Alzheimer Disease
J Neuro-Ophthalmol 29:149-150, Finelli,P.F., 2009
Lyme Neuroborreliosis: Manifestations of a Rapidly Emerging Zoonosis
AJNR 30:1079-1087, Hildenbrand,P.,et al, 2009
Use of Antithrombotic Drugs and the Presence of Cerebral Microbleeds: The Rotterdam Scan Study
Arch Neurol 66:714-720,691, Vernooij,M.W.,et al, 2009